Opening soon!
Location – opening in November 2024
Located strategically within Bayer Pharmaceuticals’ global HQ campus, Bayer Co.Lab Berlin offers direct access to expertise in R&D, manufacturing, regulatory, medical and other domains. Our on-site collaborative environment includes a growing number of innovative companies and service providers like CDMO/CRO Nuvisan. Just a 10-minute ride from Berlin Central Station, Bayer Co.Lab is in the heart of the city near world renowned research and clinical institutions like the Charité, the Max Delbrück Center (MDC), and the Berlin Institute of Health (BIH). The upcoming
Berlin Center for Gene & Cell Therapies will host Co.Lab Berlin as of 2028 and will further strengthen this vibrant ecosystem and offer a pathway for growth to our resident companies. Bayer Co.Lab Berlin, aligning with the visions of the
National Strategy for Gene and Cell Therapies and the
Bayer Life Sciences Campus project, is a launchpad for start-ups and entrepreneurs to play a central role in Berlin’s biotech boom.
Bayer Co.Lab Berlin is currently welcoming applications from start-up companies working in the ATMP and / or oncology fields. Applications are accepted on a rolling basis.
Our local offering to biotech start-ups
State-of-the-art facilities
Ready-to-use S1/S2 certifiable lab pods for confidential research, equipped with tissue culture hoods, incubators, centrifuges, and more. Shared lab space with larger equipment such as autoclaves, microscopes, FACS and more. Co-working office space with workstations, meeting rooms, kitchen facilities and lounge areas.
On-site expertise and partners
Access to Bayer’s on-site and global expertise across R&D, manufacturing, regulatory and other domains. Partner opportunities with other innovators and on-site service providers like CDMO/CRO Nuvisan are also available.
Ecosystem access
Facilitated connections and introductions to ecosystem partners such as investors and research partners.